INTRODUCTION
The leva tor ani muscle of the rat is hormone dependent; it undergoes atrophy following orchiectomy, and it hypertrophies when male rats are given testosterone [1 ] ,
The muscle is present in female rats at birth. Shortly thereafter, unless the animals are given andrcgens, the muscle disappears L2, 3 ]. An obvious hormonal regulator of the size of this muscle is testosterone. Recently, however, DuBois and Almon reported that castration of male rats caused a two-fold increase in the cytosolic glucocorticoid receptor in this rauscle (together with the bulbocavernosus muscle) [4] .
DuBois and
Almon also demonstrated increases in cytoplasraic glucocorticoid receptor binding in skeletal muscle folio-wing denervation [5] , disuse [6] , and in nrurine [7] or avian muscular dystrophy [8] .
Based on these results, it was hypothesized that endogenous glucocorticoids may be involved in a fundaiTiental manner in muscle atrophy in these diverse conditions [9] . Thus, maintenance of the mass of the leva tor ani muscle, and, possibly, "ordinary" rVeletal muscle, may involve a balance between the anabolic actions of androgens and the catabolic actions of glucocorticoids. We tested this hypothesis by assessing the effects of a potent and selective antiglucocorticoid, RU38'l86, on dexamethasone-and orchiectoray-induced atrophy of the rat levator ani rauscle. Hydroxylapatite was employed to separate bound and unbound ligand [12] [13] [14] .
EXPERIMENTAL
Et'nanol-extracted hydroxylapatite (2 ml) was added to 16 ml Liquiscint aqueous fluor (National Diagnostics, Soraerville, NJ), and radioactivity was determined at 32? efficiency in a Beckiaan LS-235 liquid scintillation spectrometer.
Specific binding was defined as the difference in the value of binding in the absence and in the presence of excess unlabelled steroid.
Non-collagen protein was determined as described [15] . Surprisingly, in the group treated with RU38')86 alone, the levator ani muscle wet weight was significantly (20£) larger than muscle from the untreated group (Fig. 2) . Similar changes were noted in the RNA content of levator ani muscles.
In Table I , we see that neither non-collagen protein concentration nor DNA concentration changed significantly in the dexamethasone-treated rats. There was, however, a significant loss of RHA in the dexamethasone-treated group. This effect was partly ameliorated by RU38486 (Fig. 2) .
Hypertrophy caused by HU33^36 suggested that endogenous gluocc-rti-j : Is night influence l-ivaoor -i.ii auscle weight, since RU3o^85 is a : '< ORIGINAL PAGE flS 0E POOR QUALITY antiandrogen [id]. Indeed, RU33^86 was able to prevent, to a significant degree, atrophy of the leva tor ani muscle secondary to castration (Fig. 3 )-Eight days after orchiectomy , levator ani wet weight was about ^0* of the control value. .Administration of RU38M86, beginning the day before castration and continuing daily thereafter, prevented this atrophy to a marked extent ( Fig. 3) . Table II shows RNA, DNA, and non-collagen protein data for castrated rats.
Again the DNA and non-collagen protein concentration of the muscles did not decrease. However, there was RNA loss, which was partially prevented by RU3SH86 (Table II) .
DISCUSSION
The data presented above indicate that B'JSSMSG can prevent, to a. . 
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